IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis

Endocarditis, Bacterial Clinical Trial

— IMAGE  

Official title:

Resonance Magnetic Imaging at the Acute Phase of Endocarditis: Diagnostic and Therapeutic Impact

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00144885
• Other study ID #: P040431
• Status: Completed
• Phase: N/A
• First received: September 2, 2005
• Last updated: February 11, 2009
• Start date: June 2005
• Est. completion date: December 2008

Study information

• Verified date: September 2005
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Patients with definite or possible infective endocarditis are included in this protocol, at the acute phase of the disease.

Description:

Patients with definite or possible infective endocarditis are included in this protocol, at the acute phase of the disease.

Resonance magnetic imaging (head and abdomen) will be performed systematically before Day 7.

The impact on the diagnosis and therapeutic options will be assessed, as compared to pre resonance magnetic nuclear (RMN) imaging declaration.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 150
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Acute phase of infective endocarditis

Exclusion Criteria:

• Contra indication to RMN

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Endocarditis
• Endocarditis, Bacterial

Intervention

Behavioral:
• Modification of therapy
Modification of the surgery date if adapted, modification of the antibiotics if adapted, based on RMI results

Locations

Country	Name	City	State
France	Hôpital Bichat Claude Bernard, 46 rue Henri Huchard	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Modification of therapeutic project		As soon as RMI is performed	No
Secondary	Modification of diagnostic classification (Duke modified criteria)		As soon as RMI is performed	No